Authors


Amanda Carrozza

Latest:

FDA Seeks to Address Drug Shortages

Some of the oldest and most important drugs have suddenly been subject to very short supplies.


Elizabeth Cuervo Tilson, MD, MPH

Latest:

Marketing Your CPESN Network (and your Pharmacy) to Providers and Payors

The real benefit of an elevator speech is the behind-the-scenes pre-work that was invested to clearly and concisely articulate a brand’s story and the value that it has to a targeted listener.


Scott Schn

Latest:

Drivers of Change in Pharmacy Benefit Management

Executive-level pharmacy leaders in US managed care organizations identify how healthcare reform is driving changes in pharmacy benefit management.


Raymond Ha, PharmD Candidate 2012

Latest:

A Brotherhood of Electricians Meets a New Class of Students

Pharmacy students offer free health services and screenings for union members in an annual heath fair as part of their commitment to the profession of pharmacy.


Jennifer Barrio, Associate Editor

Latest:

Advancing the Profession by Inspiring Others

RESPy winner Eliza Dy uses her pharmacy skills to help her community and motivate her classmates.


Anne Ormerod, PharmD

Latest:

Evolutions in Outpatient Cancer Care

Within the last 5 years changes to oncology private practice have led to these clinics aligning themselves with larger entities to maintain their practices.


Matthew Deans

Latest:

What Makes Specialty Infusion Pharmacy So Special?

Specialty infusion pharmacy should be thought of in terms of superlatives, such as most complex and highest cost.



Julia Tamulis

Latest:

Specialty Pharmacies Face Emerging Fraud Risk in 'Usual and Customary' Pricing

Specialty pharmacies need to track drug pricing throughout the claims adjudication process to avoid potential liability.


Linda Harris

Latest:

US Primary Care Providers' Use of Over-the-Counter Medications for Gastroesophageal Reflux Disease and Chronic Constipation

The perception and utilization of OTC medications among primary care providers for gastroesophageal reflux disease and chronic constipation shows a need for improved patient education on these medications.


Dan Leonard, President

Latest:

Evidence: Vital but Seldom Used Consistently by Payers

Peer-reviewed research conducted by the National Pharmaceutical Council (NPC) and the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center over the past 2 years sheds some light on what’s behind discrepancies in coverage decisions from one insurer to the next.


Surabhi Dangi-Garimella, PhD

Latest:

ASCEND Trial: Aspirin Prevents Serious Vascular Events in Diabetes

Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.


Joe Maki, Senior Director, Pharmacy Business Operations, Novant Health

Latest:

Strategies for Successful IDN-based Specialty Pharmacy: The Financial Perspective

An in-house specialty pharmacy can provide significant financial gain for health systems by preventing revenue from being diverted to outside pharmacies.



Howard R. Underwood, MD, MBA, MS

Latest:

Incentive Formularies: Spending and Utilization for 3 Common Drug Classes

Incentive formularies with varying cost sharing led to modestly lower overall spending, with savings for plan sponsors offset by increased out-of-pocket spending.


Eileen Myers, MPH

Latest:

Prefilled Syringe Vaccine Doses: An Emerging Option in the Retail-Based Clinic Setting

Prefilled syringe use offers advantages that can help pharmacists improve quality of care.


Eugene Borukhovich

Latest:

The Impact of Precision Medicine and the 21st Century Cures Act on Modern Pharma

The United States accounts about 40% of the global pharmaceutical market.


Timothy R. Hudd, BS, PharmD, RPh, AE-C

Latest:

Managing Severe Asthma: Key Considerations When Recommending Therapy

Advancements in the understanding of asthma pathophysiology has led to the discovery of defined asthma phenotypes and targeted interventions involving novel biologic therapies.


By Kate H. Gamble, Senior Editor

Latest:

Support for Breastfeeding Moms Lacking, Says CDC

Despite the fact that breastfeeding leads to better overall health and fewer doctor visits and prescriptions, mothers aren't getting the support they need.



Robert J. Nordyke, PhD

Latest:

Synchronization of Treatment With Erythropoiesis-Stimulating Agents and Chemotherapy

In outpatient oncology clinics, erythropoiesis-stimulating agents and chemotherapy were found to be typically administered during the same visits, as opposed to requiring separate visits.


Ann McNamara, PharmD

Latest:

The Value of Integration in a Health System Specialty Pharmacy Hepatitis C Program

Integrated, coordinated care and access to the electronic medical record provide many unique opportunities to enhance overall care and decrease costs associated with hepatitis C therapy.


Gerald L. Klein, MD

Latest:

Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBD

This pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.



Scot Walker, PharmD, MS, BCPS, BCACP

Latest:

Using Digital Media to Counsel Patients

Advancements in our ability to care for patients have enabled us to control and sometimes cure many diseases.





BY LOUIS FERRARI, MBA, RPH

Latest:

The Evolving Epilepsy Treatment Spectrum: A Review of Antiepileptic Drugs in Late Development

Given the relatively static rate of seizure freedom with the current antiepileptic drug (AED) armamentarium, a need remains for the development of new compounds to help enable more patients achieve seizure freedom. Fortunately, several investigational therapeutic agents and delivery systems are in phase 3 development, which are being investigated for the treatment of orphan diseases and focal-onset and generalized-onset seizures.